Fundz

Cardiosense reported raising $9.08 Million in an initial SEC Form D filing, from an offering of $17.7 Million

PRIVATEDec 09, 2022$9.1M of $17.7M raised

Amount Raised

$9.08 Million

$9.08 Million sold, per SEC Form D (first sale Nov 29, 2022)

Round Type

Venture

ChicagoHealth Care

Quick answer

Cardiosense raised $9.08 Million in a funding round, dated November 29, 2022. Cardiosense is based in Chicago, Illinois, United States.

How much did Cardiosense raise?
Cardiosense raised $9.08 Million in a funding round on November 29, 2022.
What does Cardiosense do?
Cardiosense is building a physiological waveform AI platform to develop predictive biomarkers to detect and manage cardiac disease.
Where is Cardiosense based and how big is it?
Cardiosense is based in Chicago, Illinois, United States. Fundz records about 38 employees.

Source: Fundz verified event record.

Who else raised in Health Care around the same time

Companies in the same sectors as Cardiosense that raised within 45 days of this round, from Fundz verified event records.

  • Minnesota Medical Technologies raised $2.1M (Seed) on January 13, 2023.
  • RightSite Health raised $7.7M on January 13, 2023.
  • Neptune Wellness Solutions raised an undisclosed amount (Debt Financing) on January 13, 2023.
  • DeepLook Medical raised $1.5M (Seed) on January 13, 2023.
  • LinusBio raised $16M (Funding Round) on January 12, 2023.
  • Wheeler Bio raised an undisclosed amount (Funding Round) on January 12, 2023.

Who to call at Cardiosense, and when

A new round usually means Cardiosense is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Cardiosense raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Cardiosense, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Cardiosense. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Cardiosense

Location

400 N. Aberdeen St.

Chicago, Illinois, United States

About

Cardiosense is building a physiological waveform AI platform to develop predictive biomarkers to detect and manage cardiac disease. The Company has developed a suite of novel digital tools, multi-sensor devices, and analysis algorithms to detect early signs of cardiovascular disease, inform personalized therapy, and improve patient outcomes.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Cardiosense raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Cardiosense's next move

See what Strategic adds

Cardiosense raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.